Eculizumab in paediatric atypical haemolytic uraemic syndrome: Lessons learned from a single-centre experience in the United Arab Emirates.
Longxiang XieOmar Al-MasriZubaida AlismailiEslam TawfikMohammed K Al-GhabraSadia H IlyasEihab Al-KhasawnehPublished in: Journal of paediatrics and child health (2019)
Our study adds to the growing body of evidence highlighting the efficacy and safety of eculizumab for the management of children with aHUS.